Ambac Financial Group (AMBC) Competitors $8.30 -0.10 (-1.19%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$8.33 +0.03 (+0.36%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AMBC vs. CLOV, YB, BOW, IGIC, TIPT, WDH, HIPO, HRTG, ACIC, and KFSShould you be buying Ambac Financial Group stock or one of its competitors? The main competitors of Ambac Financial Group include Clover Health Investments (CLOV), Yuanbao (YB), Bowhead Specialty (BOW), International General Insurance (IGIC), Tiptree Financial (TIPT), Waterdrop (WDH), Hippo (HIPO), Heritage Insurance (HRTG), American Coastal Insurance (ACIC), and Kingsway Financial Services (KFS). These companies are all part of the "insurance" industry. Ambac Financial Group vs. Its Competitors Clover Health Investments Yuanbao Bowhead Specialty International General Insurance Tiptree Financial Waterdrop Hippo Heritage Insurance American Coastal Insurance Kingsway Financial Services Ambac Financial Group (NYSE:AMBC) and Clover Health Investments (NASDAQ:CLOV) are both small-cap insurance companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability. Which has stronger valuation & earnings, AMBC or CLOV? Clover Health Investments has higher revenue and earnings than Ambac Financial Group. Clover Health Investments is trading at a lower price-to-earnings ratio than Ambac Financial Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmbac Financial Group$235.82M1.63-$556.45M-$12.10-0.69Clover Health Investments$1.37B1.03-$43.01M-$0.05-55.60 Do institutionals and insiders believe in AMBC or CLOV? 84.5% of Ambac Financial Group shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 6.2% of Ambac Financial Group shares are held by company insiders. Comparatively, 24.1% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media prefer AMBC or CLOV? In the previous week, Clover Health Investments had 3 more articles in the media than Ambac Financial Group. MarketBeat recorded 5 mentions for Clover Health Investments and 2 mentions for Ambac Financial Group. Ambac Financial Group's average media sentiment score of 1.07 beat Clover Health Investments' score of 0.61 indicating that Ambac Financial Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ambac Financial Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Clover Health Investments 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate AMBC or CLOV? Ambac Financial Group currently has a consensus target price of $12.50, suggesting a potential upside of 50.60%. Clover Health Investments has a consensus target price of $4.83, suggesting a potential upside of 73.86%. Given Clover Health Investments' higher possible upside, analysts clearly believe Clover Health Investments is more favorable than Ambac Financial Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ambac Financial Group 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Clover Health Investments 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more risk & volatility, AMBC or CLOV? Ambac Financial Group has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500. Is AMBC or CLOV more profitable? Clover Health Investments has a net margin of -1.69% compared to Ambac Financial Group's net margin of -163.67%. Ambac Financial Group's return on equity of -1.80% beat Clover Health Investments' return on equity.Company Net Margins Return on Equity Return on Assets Ambac Financial Group-163.67% -1.80% -0.28% Clover Health Investments -1.69%-7.42%-4.00% SummaryAmbac Financial Group and Clover Health Investments tied by winning 8 of the 16 factors compared between the two stocks. Get Ambac Financial Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AMBC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMBC vs. The Competition Export to ExcelMetricAmbac Financial GroupINS IndustryFinance SectorNYSE ExchangeMarket Cap$389.99M$56.03B$12.05B$20.65BDividend YieldN/A2.02%5.62%3.67%P/E Ratio-0.6916.3319.7529.03Price / Sales1.632.6025.9666.13Price / Cash36.0828.2321.3322.84Price / Book0.372.792.094.43Net Income-$556.45M$4.66B$1.00B$994.22M7 Day Performance-5.64%-2.39%-2.46%-3.39%1 Month Performance17.90%-1.97%-0.84%-2.09%1 Year Performance-31.86%20.90%537.11%10.09% Ambac Financial Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMBCAmbac Financial Group4.2455 of 5 stars$8.30-1.2%$12.50+50.6%-33.5%$389.99M$235.82M-0.69130Positive NewsUpcoming EarningsCLOVClover Health Investments3.0068 of 5 stars$3.00-1.3%$4.83+61.1%+54.4%$1.54B$1.37B0.00680Upcoming EarningsYBYuanbaoN/A$27.47-0.9%N/AN/A$1.25B$456.88M0.00497BOWBowhead Specialty3.2773 of 5 stars$32.58-1.1%$39.67+21.8%+17.2%$1.08B$425.66M23.19193Positive NewsUpcoming EarningsIGICInternational General Insurance3.8013 of 5 stars$23.32-2.8%$31.50+35.1%+36.1%$1.07B$539M8.82290Positive NewsUpcoming EarningsTIPTTiptree Financial2.008 of 5 stars$21.83+1.3%N/A+11.0%$807.68M$2.04B9.491,144News CoverageEarnings ReportDividend AnnouncementAnalyst UpgradeWDHWaterdrop3.221 of 5 stars$1.89-7.2%N/A+50.0%$739.45M$379.74M13.603,057News CoverageHIPOHippo2.3345 of 5 stars$26.33-1.9%$31.50+19.6%+54.7%$675.22M$372.10M0.00620Upcoming EarningsHRTGHeritage Insurance4.0558 of 5 stars$20.59+0.0%$29.00+40.8%+173.5%$637.84M$816.98M8.13650News CoveragePositive NewsUpcoming EarningsACICAmerican Coastal Insurance1.9363 of 5 stars$10.42-2.0%N/AN/A$514M$296.66M7.18470KFSKingsway Financial Services0.8646 of 5 stars$14.42-1.0%N/A+59.9%$401.22M$109.38M0.00280Upcoming Earnings Related Companies and Tools Related Companies Clover Health Investments Competitors Yuanbao Competitors Bowhead Specialty Competitors International General Insurance Competitors Tiptree Financial Competitors Waterdrop Competitors Hippo Competitors Heritage Insurance Competitors American Coastal Insurance Competitors Kingsway Financial Services Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AMBC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ambac Financial Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ambac Financial Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.